Discovery of a novel class of benzazepinone Nav1.7 blockers: Potential treatments for neuropathic pain

This publication has 19 references indexed in Scilit:

• Loss‐of‐function mutations in the Na_v1.7 gene underlie congenital indifference to pain in multiple human populations
  Clinical Genetics, 2007
• An SCN9A channelopathy causes congenital inability to experience pain
  Nature, 2006
• SCN9A Mutations in Paroxysmal Extreme Pain Disorder: Allelic Variants Underlie Distinct Channel Defects and Phenotypes
  Neuron, 2006
• The Role of Sodium Channels in Chronic Inflammatory and Neuropathic Pain
  The Journal of Pain, 2006
• Epidemiology of Refractory Neuropathic Pain
  Pain Practice, 2006
• Gain-of-function mutation in Nav1.7 in familial erythromelalgia induces bursting of sensory neurons
  Brain, 2005
• Functional Assay of Voltage-Gated Sodium Channels Using Membrane Potential-Sensitive Dyes
  ASSAY and Drug Development Technologies, 2004
• The Response of Neuropathic Pain and Pain in Complex Regional Pain Syndrome I to Carbamazepine and Sustained-Release Morphine in Patients Pretreated with Spinal Cord Stimulation: A Double-Blinded Randomized Study
  Anesthesia & Analgesia, 2001
• The effect of intravenous lidocaine, tocainide, and mexiletine on spontaneously active fibers originating in rat sciatic neuromas
  Pain, 1989
• Calcium Channel Receptor Binding Studies for Diltiazem and Its Major Metabolites
  Journal of Cardiovascular Pharmacology, 1987